Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGIV-HB Grifols (Niuliva) in Liver Transplant Patients
NCT00838071Phase 3Completed
- Sponsor
- Grifols
- Start
- Oct 2003
- Primary completion
- Jul 2004
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of hepatitis B immune globulin in hepatitis B (HBV), sponsored by Grifols. Started Oct 2003; status: completed.
02
Drugs
hepatitis B immune globulin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00838071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00838071.